1 results match your criteria: "Bamherzige Schwestern Hospital[Affiliation]"
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Clin Lymphoma Myeloma Leuk
November 2015
Internal Medicine I, Medical Oncology, Hematology and Gastroenterology, Bamherzige Schwestern Hospital, Linz, Austria. Electronic address:
Background: Lenalidomide has demonstrated remarkable efficacy for therapy of lower-risk myelodysplastic syndromes (MDS) associated with 5q(-). The present evaluation aimed to describe the characteristics and outcomes of low-risk MDS patients treated with lenalidomide in Austria.
Patients And Methods: For this retrospective, multicenter, observational analysis of MDS patients who received lenalidomide, data were collected at various hospitals in Austria over a period of 3 years.